GSK (LSE:GSK) Asset Impairment Charge : £0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1972. Start your Free Trial

What is GSK Asset Impairment Charge?

GSK's Asset Impairment Charge for the three months ended in Mar. 2025 was £0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was £0 Mil.

GSK Asset Impairment Charge Historical Data

The historical data trend for GSK's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Asset Impairment Charge Chart

GSK Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

GSK Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

GSK Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was £0 Mil.

GSK Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of GSK's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (LSE:GSK) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK:USA GSK1:Mexico GSK N:Mexico GSKl:UK GS70:Germany GS71:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

79 New Oxford Street, London, GBR, WC1A 1DG

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.